P183 A systematic review on outcome measures of long-term efficacy in clinical trials concerning Crohn’s disease patientsLaura Janssen, Rob H. Creemers, A Van Bodegraven|Journal of Crohn s and Colitis|2022Cited by 1
P595 Validation of a predictive algorithm for thiopurine induced hepatotoxicity in IBD patientsF Van Moorsel, Dennis R. Wong, Paul Bus et al.|Journal of Crohn s and Colitis|2022Cited by 0
P464 Rac1/pSTAT3 expression in T lymphocytes: A potential pharmacodynamic marker for thiopurines in the treatment of Inflammatory Bowel Disease patients?Debbie S. Deben, Dennis R. Wong, Rob H. Creemers et al.|Journal of Crohn s and Colitis|2022Cited by 0
P526 Measurement of thiopurine metabolites concentrations after one week of treatment does not predict treatment failure in Inflammatory Bowel Disease patientsDebbie S. Deben, A Van Bodegraven, F Van Moorsel et al.|Journal of Crohn s and Colitis|2022Cited by 0
P526 A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trialR Van Linschoten, Frank Hoentjen, Fenna M. Jansen et al.|Journal of Crohn s and Colitis|2023Cited by 0